Skip to main content

Table 1 Demographic and genotypic characteristics of subjects according to their status

From: The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels

 

Controls

HeFH

HoFH

P

Subjects (n)

117

118

6

 

Age (y)

38.7 ± 16.8

37.7 ± 11.2

27.0 ± 10.7

0.1

Sex

   

0.1

 Men (%)

68 (58.1)

55 (46.6)

2 (33.3)

 

 Women (%)

49 (41.9)

63 (53.4)

4 (66.7)

 

BMI (kg/m2)

25.2 ± 4.5

25.4 ± 4.2

24.6 ± 2.7

0.9

LDLR mutations

 Del >15 kb (%)

-

66 (55.9)

-

 

 W66G (%)

-

37 (31.4)

-

 

 Y468X (%)

-

8 (6.8)

-

 

 C646Y (%)

-

3 (2.5)

-

 

 C347R (%)

-

1 (0.8)

-

 

 C152W (%)

-

1 (0.8)

-

 

 R329X (%)

-

1 (0.8)

-

 

 Del 5 kb (%)

-

1 (0.8)

-

 

 Double Del >15 kb (%)

-

-

3 (50.0)

 

 Double W66G (%)

-

-

1 (16.7)

 

 Double C660X (%)

-

-

1 (16.7)

 

 Del 15 kb + W66G

-

-

1 (16.7)

 

Smoking

   

<0.0001

 Ever (%)

87 (74.4)

56 (47.5)

0

 

 Never (%)

30 (25.6)

62 (52.5)

6 (100.0)

 
  1. Data are listed as mean ± SD. Percentages are indicated in parentheses. All control and HeFH subjects were apoE3 homozygotes. HeFH heterozygotes for familial hypercholesterolemia, HoFH homozygotes for familial hypercholesterolemia, BMI body mass index, LDLR LDL receptor, Del deletion